Proton Therapy for Spinal Tumors: A Consensus Statement From the Particle Therapy Cooperative Group.

Markus Stock, Rovel Colaco, Sina Mossahebi, Pouya Sabouri, Michael Soike, Mark McDonald, Haibo Lin, C Jake Wang, Robert Press, Adam L Holtzman, Adam J Kole, James W Snider, Arpit M Chhabra, Heng Li, Jun Zhou, Chengyu Shi, Charles B Simone, Francesca Albertini

Journal: International journal of radiation oncology, biology, physics 2024;120(4):1135-1148

PMID: 39181272

Abstract

PURPOSE

Proton beam therapy (PBT) plays an important role in the management of primary spine tumors. The purpose of this consensus statement was to summarize safe and optimal delivery of PBT for spinal tumors.

METHODS AND MATERIALS

The Particle Therapy Cooperative Group Skull Base/Central nervous system/Sarcoma Subcommittee consisting of radiation oncologists and medical physicists with specific expertise in spinal irradiation developed expert recommendations discussing treatment planning considerations and current approaches in the treatment of primary spinal tumors.

RESULTS

Computed tomography simulation: factors that require significant consideration include (1) patient comfort, (2) setup reproducibility and stability, and (3) accessibility of appropriate beam angles.

SPINE STABILIZATION HARDWARE

If present, hardware should be placed with cross-links well above/below the level of the primary tumor to reduce the metal burden at the level of the tumor bed. New materials that can reduce uncertainties include polyether-ether-ketone and composite polyether-ether-ketone-carbon fiber implants.

FIELD ARRANGEMENT

Appropriate beam selection is required to ensure robust target coverage and organ at risk sparing. Commonly, 2 to 4 treatment fields, typically from posterior and/or posterior-oblique directions, are used.

TREATMENT PLANNING METHODOLOGY

Robust optimization is recommended for all pencil beam scanning plans (the preferred treatment modality) and should consider setup uncertainty (between 3 and 7 mm) and range uncertainty (3%-3.5%). In the presence of metal hardware, use of an increased range uncertainty up to 5% is recommended.

CONCLUSIONS

The Particle Therapy Cooperative Group Skull Base/Central nervous system/Sarcoma Subcommittee has developed recommendations to enable centers to deliver PBT safely and effectively for the management of primary spinal tumors.

Copyright © 2024 Elsevier Inc. All rights reserved.

Address: Department of Radiation Oncology, New York Proton Center, New York, New York. Electronic address: [email protected].; Department of Radiation Oncology, South Florida Proton Therapy Institute, Delray Beach, Florida.; Department of Radiation Oncology, University of Alabama, Birmingham, Alabama.; Department of Medical Physics, EBG MedAustron, Wiener Neustadt, Austria.; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.; Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida.; Department of Radiation Oncology, Willis Knighton Cancer Center, Shreveport, Louisiana.; Department of Medical Physics, Johns Hopkins, Baltimore, Maryland.; Department of Radiation Oncology, New York Proton Center, New York, New York.; Department of Medical Physics, City of Hope, Irvine, California.; Department of Radiation Oncology, Emory University, Atlanta, Georgia.; Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.; Department of Medical Physics, Maryland Proton Treatment Center, Baltimore, Maryland.; Department of Radiation Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Department of Medical Physics, Paul Scherrer Institut, Würenlingen, Switzerland.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.